Brentuximab
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Brentuximab, covering 2017-09-05 to 2023-10-26. Get the full timeline:
Most recent: Clinical Trial Update: Brentuximab for Newly Diagnosed Hodgkin Disease [Phase 2]